Invasive bladder cancer following 125iodine implants

Area of Science:

• Urologic Oncology
• Radiation Oncology
• Medical Physics

Background:

• Brachytherapy using 125iodine seeds is a common treatment for localized prostate adenocarcinoma.
• Radiotherapy, while effective, carries potential risks of secondary malignancies.
• Long-term follow-up is crucial for assessing the late effects of radiation therapy.

Observation:

• Two patients developed invasive transitional cell carcinoma of the bladder approximately six years post-125iodine seed implantation.
• Tumor locations were within the trigone and prostatic urethra, corresponding to the radiation treatment field.
• Both patients had undergone radiotherapy for localized prostate cancer.

Findings:

• The latency period of approximately six years suggests a potential link between 125iodine radiation and tumor development.
• The occurrence of high-grade transitional cell carcinoma indicates an aggressive neoplastic process.
• The localized nature of the tumors within the radiation field supports a radiation-induced etiology.

Implications:

• These cases highlight the potential tumorigenic effects of 125iodine radiation in the bladder.
• Further research is warranted to understand the mechanisms of radiation-induced carcinogenesis in this context.
• Clinicians should maintain a high index of suspicion for secondary bladder malignancies in patients treated with 125iodine brachytherapy.